[Therapy of metastatic breast cancer at the Ulm Tumor Center in 1980 and 1990].
Porzsolt
F
F
Universitätsklinikum, Tumorzentrum Ulm.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002699:Chlorambucil / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D015996:Survival Rate; D014410:Tumor Stem Cell Assay
D002699:Chlorambucil; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Therapie des metastasierenden Mammakarzinoms am Tumorzentrum Ulm 1980 und 1990.